Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,304 Followers

Comparison Results

Name
Price
Analyst Price Target
Analyst Consensus
Market Cap
P/E Ratio
Yearly Gain
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$17.36
10 Buy
0 Hold
0 Sell
Strong Buy
$12.81B
347.42%
BioMarin Pharmaceutical
$60.26
19 Buy
5 Hold
0 Sell
Strong Buy
$11.50B
27.40
-30.70%
Exelixis
$34.57
10 Buy
7 Hold
0 Sell
Moderate Buy
$9.68B
19.50
49.39%
Incyte
$60.58
6 Buy
11 Hold
1 Sell
Moderate Buy
$12.09B
223.38
9.67%
United Therapeutics
$292.46
8 Buy
3 Hold
1 Sell
Moderate Buy
$13.14B
11.89
25.22%
Genmab
$18.39
4 Buy
3 Hold
0 Sell
Moderate Buy
$11.68B
10.39
-38.21%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
17.36
13.41
339.49%
BMRN
BioMarin Pharmaceutical
60.26
-27.02
-30.96%
EXEL
Exelixis
34.57
11.22
48.05%
INCY
Incyte
60.58
5.53
10.05%
UTHR
United Therapeutics
292.46
55.50
23.42%
GMAB
Genmab
18.39
-11.47
-38.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis